Cassini® successfully closes financing round

Cassini, a pioneer in the development of corneal diagnostic solutions, announced today that it has closed a Series A financing round with venture capital fund Innovation Industries. The injection of capital will accelerate the development and successful commercialization of Cassini, a diagnostic platform for premium refractive cataract surgery procedures.

Record 12 clinical studies on improving cataract surgery outcomes with Cassini® to be presented during ESCRS

Twelve clinical studies on improving outcomes of cataract surgery with Cassini, a novel diagnostic platform based on multi-color LED technology, will be presented at the upcoming ESCRS meeting in Lisbon, Portugal from October 7-11, 2017. The studies cover a wide range of research interests, including measurement of the posterior cornea, femtosecond laser assisted arcuate incisions for treatment of astigmatism and comparative studies of Cassini and other diagnostic technologies.

Cassini receives KFDA clearance for South Korea

Cassini announced today that it has obtained approval to market the Cassini corneal shape analyzer in South Korea (ROK). This is another important milestone in the International expansion of Cassini.